Literature DB >> 8946386

Physical and functional mapping of the transcriptional start sites of Plasmodium falciparum proliferating cell nuclear antigen.

P Horrocks1, B J Kilbey.   

Abstract

RNase protection assays and primer extension analysis have been used to locate a major transcription start site 960 bp upstream from the translational start of the PfPCNA coding sequence. A second, minor, site is situated a further 40 bp upstream. Intraerythrocytic parasite stages were transiently transfected with constructs containing a firefly luciferase reporter gene under the transcriptional control of variously modified elements of the PfPCNA 5' flanking sequence. These experiments identified a 470 bp region essential for promoter activity, which contains the physically mapped transcriptional start sites. In addition, a region between 290 and 620 bp upstream of the transcriptional start sites is required for efficient promoter activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8946386     DOI: 10.1016/0166-6851(96)02737-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  10 in total

1.  Analysis of the molecular mechanisms governing the stage-specific expression of a prototypical housekeeping gene during intraerythrocytic development of P. falciparum.

Authors:  Eleanor H Wong; Sandra Hasenkamp; Paul Horrocks
Journal:  J Mol Biol       Date:  2011-02-24       Impact factor: 5.469

2.  An improved single-step lysis protocol to measure luciferase bioluminescence in Plasmodium falciparum.

Authors:  Sandra Hasenkamp; Eleanor H Wong; Paul Horrocks
Journal:  Malar J       Date:  2012-02-10       Impact factor: 2.979

Review 3.  Enlightening the malaria parasite life cycle: bioluminescent Plasmodium in fundamental and applied research.

Authors:  Giulia Siciliano; Pietro Alano
Journal:  Front Microbiol       Date:  2015-05-11       Impact factor: 5.640

4.  Tumor necrosis factor reduces Plasmodium falciparum growth and activates calcium signaling in human malaria parasites.

Authors:  Laura N Cruz; Yang Wu; Henning Ulrich; Alister G Craig; Célia R S Garcia
Journal:  Biochim Biophys Acta       Date:  2016-04-11

5.  Histone modifications associated with gene expression and genome accessibility are dynamically enriched at Plasmodium falciparum regulatory sequences.

Authors:  Jingyi Tang; Scott A Chisholm; Lee M Yeoh; Paul R Gilson; Anthony T Papenfuss; Karen P Day; Michaela Petter; Michael F Duffy
Journal:  Epigenetics Chromatin       Date:  2020-11-23       Impact factor: 4.954

6.  Efficient generation of mNeonGreen Plasmodium falciparum reporter lines enables quantitative fitness analysis.

Authors:  Johanna Hoshizaki; Hannah Jagoe; Marcus C S Lee
Journal:  Front Cell Infect Microbiol       Date:  2022-09-16       Impact factor: 6.073

7.  Analysis of the spatial and temporal arrangement of transcripts over intergenic regions in the human malarial parasite Plasmodium falciparum.

Authors:  Karen Russell; Sandra Hasenkamp; Richard Emes; Paul Horrocks
Journal:  BMC Genomics       Date:  2013-04-19       Impact factor: 3.969

8.  Diverse expression patterns of subgroups of the rif multigene family during Plasmodium falciparum gametocytogenesis.

Authors:  Michaela Petter; Insa Bonow; Mo-Quen Klinkert
Journal:  PLoS One       Date:  2008-11-20       Impact factor: 3.240

9.  In silico discovery of transcription regulatory elements in Plasmodium falciparum.

Authors:  Jason A Young; Jeffery R Johnson; Chris Benner; S Frank Yan; Kaisheng Chen; Karine G Le Roch; Yingyao Zhou; Elizabeth A Winzeler
Journal:  BMC Genomics       Date:  2008-02-07       Impact factor: 3.969

10.  Genome-wide analysis of the human malaria parasite Plasmodium falciparum transcription factor PfNF-YB shows interaction with a CCAAT motif.

Authors:  Wânia Rezende Lima; David Correa Martins; Kleber Simônio Parreira; Pedro Scarpelli; Miriam Santos de Moraes; Pantelis Topalis; Ronaldo Fumio Hashimoto; Célia R S Garcia
Journal:  Oncotarget       Date:  2017-12-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.